1. Home
  2. IIM vs LAB Comparison

IIM vs LAB Comparison

Compare IIM & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IIM
  • LAB
  • Stock Information
  • Founded
  • IIM 1993
  • LAB 1999
  • Country
  • IIM United States
  • LAB United States
  • Employees
  • IIM N/A
  • LAB N/A
  • Industry
  • IIM Investment Managers
  • LAB Biotechnology: Laboratory Analytical Instruments
  • Sector
  • IIM Finance
  • LAB Industrials
  • Exchange
  • IIM Nasdaq
  • LAB Nasdaq
  • Market Cap
  • IIM 584.6M
  • LAB 562.1M
  • IPO Year
  • IIM N/A
  • LAB 2011
  • Fundamental
  • Price
  • IIM $12.40
  • LAB $1.30
  • Analyst Decision
  • IIM
  • LAB Strong Buy
  • Analyst Count
  • IIM 0
  • LAB 2
  • Target Price
  • IIM N/A
  • LAB $2.88
  • AVG Volume (30 Days)
  • IIM 122.2K
  • LAB 1.8M
  • Earning Date
  • IIM 01-01-0001
  • LAB 02-26-2025
  • Dividend Yield
  • IIM 4.63%
  • LAB N/A
  • EPS Growth
  • IIM N/A
  • LAB N/A
  • EPS
  • IIM 0.02
  • LAB N/A
  • Revenue
  • IIM N/A
  • LAB $155,902,000.00
  • Revenue This Year
  • IIM N/A
  • LAB $62.60
  • Revenue Next Year
  • IIM N/A
  • LAB $9.19
  • P/E Ratio
  • IIM $591.50
  • LAB N/A
  • Revenue Growth
  • IIM N/A
  • LAB 48.23
  • 52 Week Low
  • IIM $9.94
  • LAB $1.17
  • 52 Week High
  • IIM $12.32
  • LAB $3.04
  • Technical
  • Relative Strength Index (RSI)
  • IIM 63.31
  • LAB 35.51
  • Support Level
  • IIM $12.34
  • LAB $1.17
  • Resistance Level
  • IIM $12.47
  • LAB $1.51
  • Average True Range (ATR)
  • IIM 0.09
  • LAB 0.10
  • MACD
  • IIM 0.02
  • LAB 0.00
  • Stochastic Oscillator
  • IIM 82.05
  • LAB 32.50

About IIM Invesco Value Municipal Income Trust

Invesco Value Municipal Income Trust is a diversified, closed-end management investment company. Its investment objective is to provide common shareholders with current income which is exempt from federal income tax.

About LAB Standard BioTools Inc.

Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.

Share on Social Networks: